1. 2001 DATA BOOK

2. NOTE FROM INVESTOR RELATIONS CONTENTS
On February 11, 2002, DuPont announced the 1 DuPont Leadership
alignment of its businesses into five market- and
technology-focused Growth Platforms as well as 2 2001 @ a Glance
the intention to create and ultimately separate a
Textiles and Interiors subsidiary (DTI). These 4 Corporate Financial Data
actions mark the next major step towards becom-
ing a sustainable growth company. 15 The DuPont Commitment:
In 2001 DuPont reported its financial results by Safety, Health and the Environment
the nine reporting segments described in our 2001
Annual Report. Under the former reporting struc- 16 2001 Reporting Segments
ture, the Strategic Business Units were the operat-
Polyester
Agriculture & Nutrition
ing units. Going forward, the operating units of
DuPont are the five Growth Platforms and DTI. Specialty Fibers
Nylon
Our 2002 financial reporting segments will coin-
Specialty Polymers
Performance Coatings
cide with these new operating units and will
& Polymers
reflect how the businesses are now managed. Pharmaceuticals
Pigments & Chemicals
To help Data Book users better understand the
Other
transformation, we present 2001 performance
information under both reporting structures. This 24 Organizing for Sustainable Growth
year’s Data Book begins with corporate financial
data and proceeds to segment overviews orga- 28 2002 Reporting Segments
nized by the 2001 reporting segments – both of
Agriculture & Nutrition Safety & Protection
these sections parallel the 2001 Annual Report.
The third section gives an overview of the realign- Coatings & Color Technologies Textiles & Interiors
ment, and the fourth section presents reclassified
Electronic & Communication Pharmaceuticals
financial, product and operations data under the
Technologies
new reporting segments. Other
Performance Materials
By organizing the data this way, we have provided
a guide to the operating transition that DuPont will
48 Sites and Principal Products
undergo in 2002. We hope you find this useful.
DUPONT INVESTOR RELATIONS
Main Office Number: (302) 774-4994 Fax: (302) 773-2631 Internet: www.dupont.com
Raymond G. Anderson Joyce A. McGhee Diane F. Eller
Ann K. M. Gualtieri
Director Manager Administrative Assistant
Vice President
(302) 774-1125 (302) 774-6088 (302) 774-9870
DuPont Investor Relations
(302) 774-0583
DuPont DATA BOOK has been prepared to assist financial analysts, portfolio managers and others in understanding and evaluating the
company. This book presents graphics, tabular and other statistical data about the consolidated company and its business segments. Dollars
are in millions except per share or where otherwise indicated. Most notes to financial statements are not included. This information is only a
summary and should be read in conjunction with the company’s audited consolidated financial statements and “Management’s Discussion
and Analysis” located in the 2001 Annual Report and on Form 10K filed with the Securities and Exchange Commission.
DuPont DATA BOOK is now available on the Web at www.dupont.com.
The DuPont Oval Logo, DuPont TM, The miracles of science ® and all products denoted with TM or ® are trademarks or registered trademarks of
E.I. du Pont de Nemours and Company or its affiliates.
June 2002

3. SENIOR LEADERS
BOARD OF DIRECTORS
Alain J. P. Belda * ††
Chairman and Chief Executive Officer,
Alcoa Inc.
Richard H. Brown *
Chairman and Chief Executive Officer,
EDS
Thomas M. Connelly v Richard R. Goodmanson v
Edward J. Donnelly Diane H. Gulyas
Curtis J. Crawford † †††
Senior Vice President & Group Vice President Executive Vice President Group Vice President
Chairman,
Chief Science & DuPont Coatings & & Chief Operating Officer DuPont Electronic
ON Semiconductor Company
Technology Officer Color Technologies & Communication
Technologies
Louisa C. Duemling **
Edward B. du Pont †††
Charles O. Holliday, Jr. *
Chairman of the Board and
Chief Executive Officer
Deborah C. Hopkins †
Senior Advisor,
Marakon Associates
Charles O. Holliday, Jr. v
John W. Himes John C. Hodgson W. Donald Johnson
Lois D. Juliber * ††
Senior Vice President Executive Vice President Chairman & Chief Group Vice President
Chief Operating Officer,
DuPont Corporate Strategy Executive Officer DuPont Operations
Colgate-Palmolive Company
& Services
Göran Lindahl * **
Chairman, Alliance for
Global Sustainability
Masahisa Naitoh †
Executive Vice Chairman,
ITOCHU Corporation
William K. Reilly ** †††
President and Chief Executive Officer,
Aqua International Partners LP
Former Administrator,
Ellen J. Kullman George F. MacCormack Steven R. McCracken Howard L. Minigh
U.S. Environmental Protection Agency
Group Vice President Group Vice President Group Vice President Group Vice President
DuPont Safety DuPont Textiles DuPont Textiles DuPont Agriculture
H. Rodney Sharp, III † ††
& Protection & Interiors & Interiors & Nutrition
Charles M. Vest †
President, Massachusetts
Institute of Technology
Board Committees:
† Audit
†† Compensation
††† Corporate Governance
** Environmental Policy
* Strategic Direction
Dennis Zeleny5
Stacey J. Mobley v Gary M. Pfeiffer v
Craig G. Naylor
Senior Vice President Group Vice President Senior Vice President Senior Vice President
Chief Administrative DuPont Performance & Chief Financial Officer Global Human Resources
Officer & General Counsel Materials
v
Member, Office of the Chief Executive
D P 1
U ONT

4. 2001 @ A GLANCE
DuPont entered a licensing and technology transfer agreement
During 2001, DuPont continued its focus on strategic actions to
with Osram Opto Semiconductors to manufacture polymer-
strengthen its portfolio and to expand its growth technologies
based organic light emitting displays (poly-OLEDs), based on
and businesses, while executing against a challenging economic
technology from UNIAX Corp., a subsidiary of DuPont. Flat
environment. We continued our transformation to a sustainable
panel displays is one of the fastest growing markets within
growth company, pursuing the three strategic initiatives that
both business and home electronics, providing increased
have guided our direction since 1998: Integrated Science,
benefits for end users in wireless applications, including light
Knowledge Intensity and Productivity through Six Sigma.
weight, increased contrast and brightness, and power
During 2001, DuPont also took additional steps toward active
efficiency.
transformation of the company:
APRIL
DuPont Pharmaceuticals was sold to Bristol-Myers Squibb for
s
almost $8 billion. The cash payment provided the company DuPont announced that it will discontinue the manufacture of
with the flexibility to further invest in its growth businesses, its fungicide benomyl and will phase out sales of Benlate® in all
reduce net debt and complete the stock repurchase program forms from the global market by December 31, 2001.
announced in 2000.
MAY
The Polyester business was repositioned further with a series
s
DuPont formed a new fabric trademark,
of joint ventures, alliances and asset sales, reducing capital
allocation from DuPont. NeotisTM, and created NeotisTM Studio, a global
business unit and direct source for unconven-
DuPont completed several smaller acquisitions designed to
s
tional engineered apparel fabric varieties.
strengthen the company’s technology position in displays.
NeotisTM Studio fabrics combine the 40-year
Additional highlights of the year’s activities included: textile expertise of Lycra® with the distinctive
attributes of nonwoven and other engineered
JANUARY
substrate technologies to add comfort and
DuPont and Air Products and Chemicals, Inc. formed a joint performance features.
venture to develop, manufacture and market colloidal silica-
The BAX ® system helps
JUNE
based slurries for applications such as silicon wafer polishing
protect food supplies.
Further supporting DuPont’s efforts to
and chemical mechanical planarization (CMP) of integrated
circuits. These processes are critical to the manufacture of advance poly-OLED technology, DuPont signed a key
semiconductors and represent markets that are growing on development agreement with Vitex, a developer of ultra-barrier
average in excess of 25 percent per year. films, for the development of innovative plastic substrates and
DuPont introduced the high-barrier materials for use in poly-OLED displays.
DuPont agreed to acquire the Yun Meng Protein Co. in China as
first fully integrated,
production-capable digital part of the company’s strategy to expand its high-value soy
textile printing solution for protein business in Asia.
home furnishings and
DuPont reached a definitive agreement to sell certain of its
related industries, using
U.S. Polyester Enterprise businesses and manufacturing assets
proprietary Artistri TM
to Alpek.
technology and the
JULY
DuPont Ink Jet 3210 printer.
DuPont and Shipley HD-MicroSystems, a joint venture of DuPont and Hitachi,
Artistri TM technology for digital
Microelectronics, a wholly expanded production of its HD-8000 series of photodefinable
textile printing.
owned subsidiary of Rohm polyimides for single mask, stress buffer passivation
and Haas Company, agreed to jointly develop and produce fully applications on semiconductor devices.
formulated 157 nanometer photoresists and anti-reflective DuPont began expansion of its Kevlar® fiber production facility
coatings for future generations of semiconductor chips. in Richmond, Virginia, including a new production line based on
proprietary DuPont fiber technology. Increased capacity should
FEBRUARY
be available by the end of 2002.
DuPont dedicated the world’s first continuous polymerization
DuPont reached agreement with Toray Industries and DuPont-
plant for making its new SoronaTM 3GT polymer. The continuous
Toray on a technical license to manufacture and market fibers
process results in a uniform polymer that answers the demand-
made from SoronaTM 3GT polymer.
ing standards of textile fibers manufacturers, who require a
uniform, consistent, high-quality polymer. 1,3 propanediol, or AUGUST
PDO, which is a key ingredient in SoronaTM, is currently made
DuPont launched a new consumer ingredient-branding
via a petroleum-based process. However, DuPont is developing
program for soy protein, introducing healthy food ingredients
a biotechnology process using sugar from corn or other crops
marketed under the brand name SolaeTM.
as the raw material for PDO.
2 D P
U ONT

5. DuPont formed a joint venture with Label DuPont SafeReturnsTM, an integrated
Systems, Inc., DuPont Authentication Systems, safety program to reduce employee injuries,
to provide enhanced security solutions for reached a significant milestone – coverage of
the product authentication and personal 100,000 people – with the signing of a five-year
security markets. contract with The Los Angeles County
Metropolitan Transportation Authority
DuPont introduced a new generation of
(MTA) Board.
protective body armor made with Kevlar®
MTP TM (multiple threat protection) technology. DECEMBER
The concealable, soft body armor is
Growers planting Pioneer® brand hybrids
specifically engineered to counter threats
Conveyors made of Delrin ® acetal won 26 of 27 categories in the 2001 National
from firearms and ice-pick type weapons.
resin modified with Kevlar ® fiber run Corn Growers Association Yield Contest –
without lubricants.
SEPTEMBER including first place in all nine categories.
DuPont and H Power Corp, a leading fuel cell development Pioneer ® hybrids out-yielded competitive brands nationally by
company, signed a joint development agreement aimed at an average of 7.1 bushels per acre, and one grower broke the
developing direct methanol fuel cells (DMFC) for portable and 400-bushel per acre mark for the first time in contest history.
mobile applications.
DuPont and MIECO Inc., a subsidiary of Tokyo-based general
DuPont won several notable awards in 2001:
trading company Marubeni Corporation, announced the first-
ever transaction of greenhouse gas emissions allowances
Ranked Number 1 as the most socially responsible U.S.
under the United Kingdom’s newly developed program. The
company in the Fortune survey of “America’s Most
transaction marked an important milestone in the development
Admired Companies.”
of market mechanisms to limit greenhouse gas emissions.
Received the prestigious “Kwaliteit van Werk, Kwaliteit
OCTOBER
van Leven” (“Quality of Work Means Quality of Life”)
DuPont received $7.8 billion in cash with the completion of the award from the government of Belgium, recognizing
sale of its Pharmaceuticals business to Bristol-Myers Squibb. DuPont as the country’s most employee-friendly company.
DuPont maintained its interest in Cozaar® / Hyzaar®, anti- Ranked Number 5 on the list of most desirable places for
hypertensive drugs discovered by DuPont and marketed by disabled persons to work in the United States, according
Merck Co. to an annual survey by Careers the Disabled magazine.
DuPont and Monsanto Company announced that they had Ranked DuPont Iberica as the most ethical and socially
resolved, on mutually beneficial terms, the issues related to responsible company in Spain in a survey by Cinco Dias,
Monsanto’s MON810 YieldGard® insect-protected corn trait a leading economic daily newspaper.
used in Pioneer Hi-Bred’s corn hybrids.
Ranked among the top U.S. employers for women
DuPont and Cambridge Display Technology entered into a engineers in a survey by Woman Engineer magazine.
strategic agreement to advance the commercialization of light
Named to Fortune magazine’s list of the 50 best U.S.
emitting polymer (LEP) displays, also known as polymer organic
companies for minorities.
light emissive displays. This venture is focused on furthering
For the fourth consecutive year, named one of “The 50
the commercialization of LEPs used to create ultra-thin,
Best Companies for Latinas to Work for in the U.S.” by
lightweight and low-power displays for electronic
LatinaStyle magazine.
products such as mobile phones, hand-held
Named as one of only five chemical companies to
notebooks and other electronic products.
London’s FTSE (Financial Times Stock Exchange) list of
100 socially responsible global companies.
Highlighted DuPont TM Coolmax ®/X-Static ® as one of the
“best of the new innovations” in the October edition of
Money magazine.
Honored DuPont Chairman and CEO Chad Holliday with
the Government of Singapore’s National Day Award, a
prestigious public service award that recognizes
Surlyn Reflections
® ®
individuals for their outstanding personal contributions
supergloss alloys
to Singapore’s economic well being and active promotion
deliver scratch-
resistant color. of the country’s interests.
D P 3
U ONT

6. CORPORATE FINANCIAL DATA
Corporate Highlights 2001 2000
(dollars in millions, except per share)
Operating Results Sales 24,726 28,268
Underlying Income from Continuing Operations 1,251 2,878
Reported Income from Continuing Operations 4,328 1 2,314
Reported Income from Discontinued Operations – –
Net Income 4,339 2,314
Depreciation 1,320 1,415
Cash Provided by Continuing Operations 2,419 5,070
Capital Expenditures 1,634 2,022
Research and Development Expense 4 1,588 1,776
Financial Position, Total Assets 40,319 39,426
Year End Working Capital 6,734 2,401
Total Debt 6,814 9,905
Stockholders’ Equity 14,452 13,299
Data Per Common Share Earnings from Continuing Operations – Underlying 5 1.19 2.73
Earnings from Continuing Operations – Reported 5 4.15 1 2.19
Earnings from Discontinued Operations – Reported 5 – –
Earnings 5 4.16 2.19
Dividends 1.40 1.40
Market Price – Year-End Close 42.51 48.31
High-Low Range 49.88 – 32.64 74.00 – 38.19
Book Value at Year-End 14.20 12.57
Average Number of Shares (millions) – Diluted 1,041 1,051
Shares Outstanding – Year-End (millions) 1,002 1,039
Ratios Total Stockholder Return (9)% (24.5)%
Dividend Yield 6 3.3% 2.9%
Share Price Appreciation (12)% (26.7)%
Continuing Operations P/E on Year-End Market Price – Underlying 36 18
Dividend Payout, as percentage of:
Underlying Continuing Operations Earnings 117% 51%
Cash Provided by Continuing Operations 62% 29%
Cash Provided by Continuing Operations per Share 5 2.32 4.82
Return on Average Stockholders’ Equity – Underlying 9.4% 21.8%
Return on Average Investors’ Capital – Underlying 7 6.8% 13.8%
Cash Provided by Continuing Operations as Percentage of Total Debt 35% 51%
Debt to Total Capital 29% 42%
Current Ratio 1.8 1.3
Other Totals Number of Employees – Year-End (thousands)
Continuing Operations 79 93
Discontinued Operations 8 – –
Total 79 93
1 Excludes cumulative effect of a change in accounting principle.
2 Excludes extraordinary item.
3 Includes strategic acquisitions of $4,905, $3,177 and $4,736 in 1999, 1998 and 1997, respectively.
4 Excludes purchased in-process research and development.
5 Diluted, based on average number of common shares.
6 Based on year-end share price.
7 Proforma return on average investors’ capital reflecting the impact of the Conoco split-off on stockholders’ equity and debt equals 16% for 1999, and averaged 17% for 1995 to 1998.
8 Divestiture of Conoco completed August 6, 1999.
4 D P
U ONT

7. 1999 1998 1997
26,918 24,767 24,089 Dividends Per Share
Earnings Per Share – Diluted
2,843 2,913 3,108 Continuing Operations Before One-Time Items
219 1,648 1,432
(dollars) (dollars)
7,471 3,033 973
$1.50
$3.00
7,690 4,480 2,405
1,444 1,452 1,361 $2.50
4,840 4,132 4,027
$1.25
$2.00
6,988 3 5,480 3 7,075 3
1,617 1,308 1,072 $1.50
40,777 38,536 36,689 $1.00
$1.00
1,425 (2,374) (2,110)
$0.50
11,566 11,124 12,049
12,875 13,954 11,270
1997 1998 1999 2000 2001
1997 1998 1999 2000 2001
2.58 2.55 2.70
0.19 1.43 2 1.24
6.80 2.65 0.84
6.99 4.08 2 2.08
1.40 1.365 1.23
65.88 53.06 60.06
75.19 – 50.06 84.44 – 51.69 69.75 – 46.38
Five-Year Performance 1997– 2001
12.09 12.18 9.77
1,098 1,145 1,150
Stockholder Return DuPont SP 500
1,045 1,126 1,130
Dividend Yield 2.6% 1.3%
26.8% (9.4)% 30.3%
2.1% 2.6% 2.0% Share Price Annual Appreciation (2)% 9.2%
24.1% (11.7)% 27.6%
26 21 22 Total Annual Return* 0.5% 10.7%
Dividend Growth 4.7% 1.1%
53% 53% 45%
31% 37% 35%
4.41 3.61 3.50
Ten-Year Performance 1992–2001
21.5% 24.2% 27.5%
13.4% 12.4% 15.1%
Stockholder Return DuPont SP 500
42% 37% 33%
46% 43% 51% Dividend Yield 2.9% 1.9%
1.1 0.8 0.8
Share Price Annual Appreciation 6.2% 10.7%
94 84 82 Total Annual Return* 9.3% 12.9%
– 17 16
Dividend Growth 5.2% 2.6%
94 101 98
* Assumes a steady compounded rate of return over the period shown and includes
reinvestment of dividends.
D P 5
U ONT

8. CORPORATE FINANCIAL DATA
Segment Information 1 2001 2000 1999
(dollars in millions)
Sales
Agriculture Nutrition 4,316 4,461 3,019
Nylon 2,696 3,149 3,068
Performance Coatings Polymers 5,754 6,485 6,111
Pharmaceuticals 902 1,487 1,630
Pigments Chemicals 3,554 3,907 3,660
Polyester 1,895 2,278 2,401
Specialty Fibers 4,418 4,959 5,080
Specialty Polymers 3,875 4,508 4,255
Other 279 443 480
Total Segment Sales 2 27,689 31,677 29,704
Elimination of Transfers (480) (642) (733)
Elimination of Equity Affiliate Sales (2,493) (2,773) (2,057)
Miscellaneous 10 6 4
Total Sales per Consolidated Financial Statements 24,726 28,268 26,918
After-Tax Operating Income – Underlying
Agriculture Nutrition 244 345 158
Nylon 60 258 303
Performance Coatings Polymers 377 733 645
Pharmaceuticals 58 133 263
Pigments Chemicals 469 715 633
Polyester (74) 62 (53)
Specialty Fibers 387 740 831
Specialty Polymers 402 714 666
Other (64) (23) 18
Total Underlying After-Tax Operating Income 1,859 3,677 3,464
(311) (493) (330)
Interest and Exchange Gains (Losses)
Corporate Expenses (281) (306) (291)
Corporate Minority Interest (16) – –
Underlying Income from Continuing Operations 1,251 2,878 2,843
Net One-Time Items 3 3,077 (564) (2,624)
Reported Income from Continuing Operations 4,328 2,314 219
1 Based on 2001 Reporting Segments.
2 Sales include pro rata equity affiliate sales and transfers.
3 For complete details of net one-time items, see DuPont Annual Report.
DuPont’s Share of DuPont’s Share of
Equity Affiliate Sales Equity Affiliate Earnings
2001 2000 1999 2001 2000 1999
Equity Affiliate Analysis
Agriculture Nutrition 188 190 548 (13) (13) 22
Nylon 160 118 113 (9) 33 29
Performance Coatings Polymers 627 726 681 13 67 60
Pharmaceuticals – – – – – –
Pigments Chemicals 58 94 88 1 3 2
Polyester 868 970 114 (62) 23 (13)
Specialty Fibers 285 336 298 3 36 42
Specialty Polymers 214 266 215 20 41 27
Other 93 73 – – 8 (4)
Total Segments 2,493 2,773 2,057 (47) 198 165
6 D P
U ONT

9. 2001 2000
1st 2nd 3rd 4th Full Yr. 1st 2nd 3rd 4th Full Yr.
Sales
Agriculture Nutrition 1,538 1,517 546 715 4,316 1,549 1,650 586 676 4,461
Nylon 674 708 675 639 2,696 749 804 807 789 3,149
Performance Coatings Polymers 1,458 1,514 1,381 1,401 5,754 1,653 1,716 1,572 1,544 6,485
Pharmaceuticals 205 304 393 – 902 389 394 389 315 1,487
Pigments Chemicals 951 952 866 785 3,554 960 1,038 974 935 3,907
Polyester 503 543 429 420 1,895 516 613 594 555 2,278
Specialty Fibers 1,186 1,141 1,060 1,031 4,418 1,316 1,284 1,213 1,146 4,959
Specialty Polymers 1,039 1,009 937 890 3,875 1,091 1,151 1,124 1,142 4,508
Other 81 81 67 50 279 123 143 105 72 443
Total Segment Sales 1 7,635 7,769 6,354 5,931 27,689 8,346 8,793 7,364 7,174 31,677
After-Tax Operating Income – Underlying
Agriculture Nutrition 249 206 (118) (93) 244 233 278 (85) (81) 345
Nylon 17 2 25 16 60 67 74 58 59 258
Performance Coatings Polymers 132 77 75 93 377 179 190 170 194 733
Pharmaceuticals (64) 10 84 28 58 54 51 41 (13) 133
Pigments Chemicals 124 123 112 110 469 164 186 169 196 715
Polyester (8) (17) (20) (29) (74) 4 8 20 30 62
Specialty Fibers 151 104 65 67 387 227 191 182 140 740
Specialty Polymers 130 85 90 97 402 165 183 175 191 714
Other 3 (1) (29) (37) (64) – 6 (5) (24) (23)
Total 734 589 284 252 1,859 1,093 1,167 725 692 3,677
Interest and Exchange Gain (Losses) (97) (88) (72) (54) (311) (123) (136) (122) (112) (493)
Corporate Expenses (70) (69) (76) (66) (281) (72) (82) (66) (86) (306)
Corporate Minority Interest – – (8) (8) (16) – – – – –
Underlying Income from Continuing Operations 567 432 128 124 1,251 898 949 537 494 2,878
After-Tax Impact of One-Time Items
In-Process Research Development 11 11
Gains/Losses on Business Divestitures,
Restructuring Charges, etc. (679) 14 3,791 3,126 (123) (59) (29) (211)
Interest, Exchange, Corporate and Tax Items – 19 19
Joint Ventures and Other Investments 34 34 78 (191) (113)
Discontinuation of Certain Products,
Misc. Asset Sales, Write-downs, and Other (83) (83) (106) (138) (13) (13) (270)
Net Impact (83) (645) 14 3,791 3,077 (95) (261) 25 (233) (564)
Reported Income from Continuing Operations 2 484 (213) 142 3,915 4,328 803 688 562 261 2,314
2001 2000
1st 2nd 3rd 4th Full Yr. 1st 2nd 3rd 4th Full Yr.
Earnings Per Share of Common Stock – Diluted 3
Underlying Earnings from Continuing Operations .54 .41 .12 .12 1.19 .85 .90 .51 .47 2.73
One-Time Items (.08) (.62) .01 3.70 2.96 (.09) (.25) .02 (.22) (.54)
Reported Earnings from Continuing Operations .46 (.21) .13 3.82 4.15 .76 .65 .53 .25 2.19
1 Sales include pro rata equity affiliate sales and intersegment transfers.
2 For complete details of earnings adjusted for one-time items, see the DuPont quarterly earnings releases.
3 Earnings per share for the year may not equal the sum of quarterly earnings per share due to changes in average share calculations.
D P 7
U ONT

10. CORPORATE FINANCIAL DATA
Consolidated Income Statement 2001 2000 1999 1998 1997
(dollars in millions, except per share)
Sales 24,726 28,268 26,918 24,767 24,089
Other Income 1 644 934 974 981 1,005
Total 25,370 29,202 27,892 25,748 25,094
Cost of Goods Sold and Other Operating Charges 16,727 18,207 16,991 15,556 15,544
Selling, General and Administrative Expenses 2,925 3,041 2,595 2,115 2,061
Depreciation 1,320 1,415 1,444 1,452 1,361
Amortization of Goodwill and Other Intangible Assets 434 445 246 108 20
Research and Development Expense 1,588 1,776 1,617 1,308 1,072
Interest Expense 590 810 535 520 389
Purchased In-Process Research and Development – (11) 2,250 1,443 1,478
Employee Separation Costs and Write-Down of Assets 1,078 101 524 633 340
Gain on Sale of DuPont Pharmaceuticals (6,136) – – – –
Gain on Issuance of Stock by Affiliates – Nonoperating – (29) – – –
Total 18,526 25,755 26,202 23,135 22,265
Income from Continuing Operations Before Income Taxes
and Minority Interests 6,844 3,447 1,690 2,613 2,829
Provision for Income Taxes 2,467 1,072 1,410 941 1,354
Minority Interests in Earnings of Consolidated Subsidiaries 49 61 61 24 43
Income from Continuing Operations 4,328 2,314 219 1,648 1,432
Discontinued Operations
Income from Operations of Discontinued Business,
Net of Taxes – – – 594 973
Gain on Disposal of Discontinued Business,
Net of Taxes – – 7,471 2,439 –
Income Before Extraordinary Item and Cumulative Effect
of a Change in Accounting Principle 4,328 2,314 7,690 4,681 2,405
Extraordinary Charge from Early Extinguishment of Debt,
Net of Taxes – – – (201) –
Cumulative Effect of a Change in Accounting Principle,
Net of Taxes 11 – – – –
Net Income 4,339 2,314 7,690 4,480 2,405
Diluted Earnings (Loss) Per Share of Common Stock
Continuing Operations Before Extraordinary Item and
Cumulative Effect of a Change in Accounting Principle 4.15 2.19 .19 1.43 1.24
Discontinued Operations – – 6.80 2.65 .84
Before Extraordinary Item and Cumulative Effect
of a Change in Accounting Principle 4.15 2.19 6.99 4.08 2.08
Extraordinary Charge – – – (.18) –
Cumulative Effect of a Change in Accounting Principle .01 – – – –
Net Income 4.16 2.19 6.99 3.90 2.08
1 Other Income:
Equity in earnings (losses) of affiliates (43) 289 135 278 643
Royalty income 380 349 289 159 64
Interest income, net of miscellaneous interest expense 146 168 185 112 131
Gains (losses) on sales of assets 47 394 16 375 64
Miscellaneous income and expense – net 114 (266) 349 57 103
Total Other Income 644 934 974 981 1,005
8 D P
U ONT

11. December 31
Consolidated Balance Sheet 2001 2000 1999 1998 1997
(dollars in millions)
Assets
Current Assets
Cash and Cash Equivalents 5,763 1,540 1,466 1,059 1,004
Marketable Securities 85 77 116 10 142
Accounts and Notes Receivable 3,903 4,552 5,318 4,201 4,309
Inventories 4,215 4,658 5,057 3,129 2,792
Prepaid Expenses 217 228 202 192 169
Deferred Income Taxes 618 601 494 645 691
Total Current Assets 14,801 11,656 12,653 9,236 9,107
Property, Plant and Equipment 33,778 34,650 35,416 34,728 32,911
Less: Accumulated Depreciation 20,491 20,468 20,545 20,597 20,310
Net Property, Plant and Equipment 13,287 14,182 14,871 14,131 12,601
Goodwill and Other Intangible Assets 6,897 8,365 8,724 2,566 1,270
Investment in Affiliates 2,045 2,206 1,459 1,796 2,372
Other Assets 3,289 3,017 3,070 2,390 2,941
Net Assets of Discontinued Operations – – – 8,417 8,398
Total 40,319 39,426 40,777 38,536 36,689
Liabilities and Stockholders’ Equity
Current Liabilities
Accounts Payable 2,219 2,731 2,780 1,929 1,921
Short-Term Borrowings and Capital Lease Obligations 1,464 3,247 4,941 6,629 6,152
Income Taxes 1,295 250 359 130 120
Other Accrued Liabilities 3,089 3,027 3,148 2,922 3,024
Total Current Liabilities 8,067 9,255 11,228 11,610 11,217
Long-Term Borrowings and Capital Lease Obligations 5,350 6,658 6,625 4,495 5,897
Other Liabilities 7,336 7,729 7,872 7,640 7,444
Deferred Income Taxes 2,690 2,105 1,660 430 500
Total Liabilities 23,443 25,747 27,385 24,175 25,058
Minority Interests 2,424 380 517 407 361
Stockholders’ Equity 14,452 13,299 12,875 13,954 11,270
Total 40,319 39,426 40,777 38,536 36,689
D P 9
U ONT

12. CORPORATE FINANCIAL DATA
Consolidated Statement of Cash Flows 2001 2000 1999 1998 1997
(dollars in millions)
Cash Provided by Continuing Operations
Net Income 4,339 2,314 7,690 4,480 2,405
Adjustments to Reconcile Net Income to Cash Provided
by Continuing Operations:
Net Income from Discontinued Operations – – (7,471) (3,033) (973)
Extraordinary Charge from Early Retirement of Debt – – – 275 –
Cumulative Effect of a Change in Accounting Principle (11) – – – –
Depreciation 1,320 1,415 1,444 1,452 1,361
Amortization of Goodwill and Other Intangible Assets 434 445 246 108 20
Purchased In-Process Research and Development – (11) 2,250 1,443 1,478
Gain on Sale of DuPont Pharmaceuticals (6,136) – – – –
Other Noncash Charges and Credits – Net 965 899 443 (319) 569
Decrease (Increase) in Operating Assets:
Accounts and Notes Receivable 435 379 (21) (580) (783)
Inventories and Other Operating Assets (362) (727) (384) (74) (355)
Increase (Decrease) in Operating Liabilities:
Accounts Payable and Other Operating Liabilities (634) 87 185 254 (20)
Accrued Interest and Income Taxes 2,069 269 458 126 325
Cash Provided by Continuing Operations 2,419 5,070 4,840 4,132 4,027
Investment Activities of Continuing Operations
Purchases of Property, Plant and Equipment (1,494) (1,925) (2,055) (2,240) (2,089)
Investments in Affiliates (140) (97) (48) (63) (1,920)
Payments for Businesses (Net of Cash Acquired) (78) (46) (5,073) (3,282) (1,238)
Proceeds from Sales of Assets 253 703 609 946 558
Net Proceeds from Sale of DuPont Pharmaceuticals 7,798 – – – –
Net Proceeds from Sale of Interest in
Petroleum Operations – – – 4,206 –
Net Decrease (Increase) in Short-Term
Financial Instruments (2) 25 (258) 131 115
Miscellaneous – Net (117) 96 14 124 552
Cash Provided by (Used for) Investment Activities
of Continuing Operations 6,220 (1,244) (6,811) (178) (4,022)
Financing Activities
Dividends Paid to Stockholders (1,460) (1,465) (1,511) (1,549) (1,401)
Net Increase (Decrease) in Short-Term Borrowings (1,588) (95) (3,244) 1,574 1,737
Long-Term and Other Borrowings:
Receipts 904 4,996 8,420 6,335 6,462
Payments (2,214) (6,574) (5,612) (8,966) (5,562)
Acquisition of Treasury Stock (1,818) (462) (690) (704) (1,747)
Proceeds from Exercise of Stock Options 153 63 168 257 116
Increase (Decrease) in Minority Interests 1,980 – 105 – (56)
Cash Provided By (Used For) Financing Activities (4,043) (3,537) (2,364) (3,053) (451)
Net Cash Flow from Discontinued Operations 1 (110) – 4,475 (568) 483
Effect of Exchange Rate Changes on Cash (263) (215) (108) 97 (99)
Increase In Cash and Cash Equivalents 4,223 74 32 430 (62)
Cash and Cash Equivalents at Beginning of Year 1,540 1,466 1,434 1,004 1,066
Cash and Cash Equivalents at End of Year 5,763 1,540 1,466 1,434 1,004
1 Includes payments of direct expenses related to the Conoco divestiture.
10 D P
U ONT

13. Selected Additional Data 2001 2000 1999 1998
(dollars in millions)
Effective Income Tax Rate
Statutory U.S. Federal Income Tax Rate 35.0% 35.0% 35.0% 35.0%
International Operations (0.8) (2.8) 4.2 2.0
Lower Effective Tax Rate on Export Sales (0.6) (1.7) (2.2) (1.9)
In-Process Research Development* – – 46.6 1.7
Other – Net 2.4 0.6 (0.2) (0.8)
Effective Income Tax Rate 36.0% 31.1% 83.4% 36.0%
* The charge associated with the 1999 Pioneer transaction was not tax effected because the purchase was a stock acquisition rather than an asset purchase.
2001 2000 1999 1998 1997
As a Percentage of Sales:
Cost of Goods Sold and Other Operating Charges 68% 64% 63% 63% 65%
Selling, General and Administrative Expenses 12 11 10 9 9
Research and Development Expense 6 6 6 5 4
Underlying Income from Continuing Operations 5 10 11 12 13
Cash Provided by Continuing Operations 10 18 18 17 17
Times Interest Earned* 4.0 5.9 7.8 7.9 11.2
* Underlying income from continuing operations before income taxes, plus interest and debt expense, divided by the sum of interest and debt expense and capitalized interest.
Research and Development Expenditures
Amount 1,558 1,776 1,617 1,308 1,072
Breakdown by Product Area:
Polymer Science 32% 30% 36% 47% 54%
Health Science 28 32 29 14 –
Agricultural Science 30 29 26 27 26
Electronic Materials 6 5 5 7 6
Chemicals 4 4 4 5 10
Other – – – – 4
Total 100% 100% 100% 100% 100%
Selected Additional Data
Annual Percent Change in Sales Versus Prior Year* (10)% 1% 0% (4)% 4%
Portion due to Selling Prices (2) (1) (3) (2) (3)
Portion due to Volume and Mix* (8) 2 3 (2) 7
Average Manufacturing Capacity Utilization 78% 81% 83% 82% 88%
* Percentage changes are calculated using sales adjusted to exclude current-year sales from acquisitions when there are no comparable prior-year sales, and to exclude
prior-year sales of businesses that have been divested.
D P 11
U ONT

14. CORPORATE FINANCIAL DATA
Selected Additional Data 2001 2000 1999
(dollars in millions)
Financial Results
Sales by Quarter
1st 6,859 7,593 6,295
2nd 6,997 7,914 7,024
3rd 5,641 6,445 6,459
4th 5,229 6,316 7,140
Total 24,726 28,268 26,918
Underlying Income from Continuing Operations
1st 567 898 749
2nd 432 949 886
3rd 128 537 625
4th 124 494 583
Total 1,251 2,878 2,843
Continuing Operations – Underlying
Earnings Per Share by Quarter – Diluted
1st .54 .85 .66
2nd .41 .90 .78
3rd .12 .51 .59
4th .12 .47 .55
Total 1 1.19 2.73 2.58
1 Earnings per share for the year may not equal the sum of quarterly earnings per share due to changes in average share calculations.
Geographic Information 2001 2000 1999
Net Net Net Net Net Net
Sales* Property Sales* Property Sales* Property
North America
United States 12,054 8,167 14,509 8,887 13,656 8,977
Canada 918 536 1,074 538 989 482
Mexico 559 164 581 165 500 146
Other 82 85 76 151 114 150
Total 13,613 8,952 16,240 9,741 15,259 9,755
Europe, Middle East and Africa
Germany 1,590 585 1,716 641 1,743 733
France 929 170 986 181 979 228
United Kingdom 704 709 783 721 960 965
Italy 854 25 915 29 884 29
Other 2,354 1,243 2,474 1,232 2,598 1,275
Total 6,431 2,732 6,874 2,804 7,164 3,230
Asia Pacific
Japan 906 75 1,023 78 928 138
Taiwan 663 632 809 680 690 769
China 623 133 487 142 361 146
Singapore 110 325 134 345 112 379
Other 1,355 127 1,506 126 1,393 197
Total 3,657 1,292 3,959 1,371 3,484 1,629
South America
Brazil 576 187 686 123 594 105
Argentina 223 102 243 118 172 126
Other 226 22 266 25 245 26
Total 1,025 311 1,195 266 1,011 257
Total 24,726 13,287 28,268 14,182 26,918 14,871
* Sales are attributed to countries based on location of customer.
12 D P
U ONT

15. Net Sales to Customers Outside the United States as a Percentage of Sales 1
2001 2000 1999
Agriculture Nutrition 52% 50% 66%
Nylon 36 35 35
Performance Coatings Polymers 62 60 58
Pharmaceuticals 34 27 22
Pigments Chemicals 45 46 44
Polyester 49 39 46
Specialty Fibers 56 54 54
Specialty Polymers 50 49 48
Other 62 34 22
Total 51% 49% 49%
1 Based on 2001 Reporting Segments.
Exports from the United States
2001 2000 1999
Sales (dollars in millions) 4,639 5,091 4,331
As a Percentage of Total Sales 19% 18% 16%
Purchased Materials and Energy Cost Index (1977 = 100; period average)
2001 2000 1999 1998 1997
Basic Materials 163 160 164 164 164
Precious Metals 289 324 240 224 184
Chemicals 178 174 157 170 185
Hydrocarbons 183 198 137 128 166
Energy 332 289 218 218 223
Total Purchased Index 200 198 164 168 181
Total Variable Cost of Goods Top Purchased Energy and Raw Materials
Primary Uses
Natural gas ........................... Nylon
Paraxylene .................... Polyester
Electricity ................... Various
Cyclohexane .............. Nylon
Ethane ......................... Packaging Polymers
Butadiene ..................... Nylon
Titanium ores .................. White Pigments
Precious metals .................. Electronics
Organic pigments .................. Performance Coatings
Fiberglass ................................. Engineering Polymers
Chlorine ........................................ White Pigments
D P 13
U ONT

16. CORPORATE FINANCIAL DATA
Selected Additional Data
Price and Volume Change Summary
Selling Price and Sales Volume Worldwide Selling Price and Sales Volume Worldwide
Percentage Change from Prior Year Indices, 1990 = 100
150
10
145
8
140
135
6
130
4
125
120
2
115
0 110
105
-2
100
-4 95
90
-6
85
80
-8
1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
Price Volume
Price Volume
Selling Price % Change from Prior Year Sales Volume % Change from Prior Year*
Year Worldwide U.S. Other Regions Year Worldwide U.S. Other Regions
1992 (1) (1) (2) 1992 4 4 6
1993 (3) 0 (7) 1993 2 1 2
1994 (1) (1) (2) 1994 9 5 15
1995 5 3 8 1995 4 1 7
1996 (1) 0 (3) 1996 3 3 4
1997 (3) 0 (7) 1997 7 5 10
1998 (2) (1) (2) 1998 (2) (3) (1)
1999 (3) (2) (4) 1999 3 1 6
2000 (1) 1 (3) 2000 2 (2) 6
2001 (2) (1) (4) 2001 (8) (12) (3)
2001 Selling Price % Change from Prior Year 2001 Sales Volume % Change from Prior Year*
Qtr Worldwide U.S. Other Regions Qtr Worldwide U.S. Other Regions
1st (2) 1 (3) 1st (4) (9) (1)
2nd (1) 1 (4) 2nd (8) (14) (3)
3rd (3) (1) (5) 3rd (9) (12) (6)
4th (3) (3) (4) 4th (9) (14) (4)
Year (2) (1) (4) Year (8) (12) (3)
* Percentage changes are calculated using sales adjusted to exclude current-year sales from acquisitions when there are no comparable prior-year sales and to exclude
prior-year sales of businesses that have been divested.
14 D P
U ONT